| Source: |
| Type: |
| TIMP-2 has been shown to have distinct effects on cancer progression compared to TIMP-1.
Research has suggested that TIMP-2 may have anti-tumor effects in certain types of cancer, including: • Inhibiting tumor growth: TIMP-2 has been shown to inhibit the growth of tumor cells in vitro and in vivo. High levels of TIMP-2 have been associated with better prognosis and improved survival in some cancers. High levels of TIMP-2 have been associated with better prognosis and improved survival in some cancers. High TIMP-2 expression: Breast, Lung, colorectal, Prostrate. Low TIMP-2 expression: Ovarian, Pancreatic, Gastric. |
| Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4) |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 3332- | SIL, | Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2 |
| - | in-vitro, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:308 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid